[
  {
    "disease_name": "脂肪肝",
    "category": "消化系统疾病",
    "information": "非酒精性脂肪性肝病常被简称为 NAFLD，是一种累及很少喝酒或完全不喝酒的人的肝脏问题。NAFLD 患者的肝脏中积聚过多脂肪。这种状况最常见于超重或肥胖症患者。随着肥胖症患者人数的增加，NAFLD 变得越来越常见，尤其是在中东和西方国家。它是世界上最常见的肝病形式。NAFLD 的严重程度不等，可能是被称为脂肪肝的肝脂肪变性，也可能是非酒精性脂肪性肝炎（NASH）这种更为严重的疾病。NASH 导致肝脏肿胀，并由于肝脏中的脂肪沉积而受损。NASH 可能恶化，并可能导致严重的肝脏瘢痕形成（称为肝硬化）甚至肝癌。目前正在将“非酒精性脂肪性肝病”这一名称更改为“代谢功能障碍相关脂肪变性肝病”（MASLD）。专家还建议将“非酒精性脂肪性肝炎”这一名称更改为“代谢功能障碍相关脂肪性肝炎”（MASH）。NAFLD 通常没有任何症状。如果有症状，则可能包括：疲劳。不舒服，或不适。腹部右上区域疼痛或不适。NASH 和肝硬化（或严重瘢痕形成）可能出现的症状包括：皮肤瘙痒。腹部肿胀，又称腹水。气短。腿部肿胀。皮肤表面下出现蜘蛛状血管。脾脏肿大。手掌发红。皮肤和眼睛发黄，即黄疸。",
    "abstract": "非酒精性脂肪性肝病（NAFLD）或代谢功能障碍相关脂肪变性肝病（MASLD）是肝脏脂肪积聚，最常见于超重或肥胖者，为全球最常见肝病。可进展为非酒精性脂肪性肝炎（NASH）或代谢功能障碍相关脂肪性肝炎（MASH），导致肝硬化、肝癌。早期常无症状，严重时出现疲劳、腹部不适、黄疸等。",
    "source": "妙佑医疗国际, https://www.mayoclinic.org/zh-hans/diseases-conditions/nonalcoholic-fatty-liver-disease/symptoms-causes/syc-20354567"
  },
  {
    "disease_name": "脂肪肝",
    "category": "消化系统疾病",
    "information": "Because MASLD typically causes no symptoms, it is often found when tests done for other reasons point to a liver condition. For example, a blood test done during a yearly exam may show high levels of liver enzymes, which can prompt more testing that leads to a MASLD diagnosis. Tests done to diagnose MASLD, rule out other diseases and see how bad the liver damage is include: Blood tests: Liver enzyme and liver function tests. Complete blood count. Iron studies. Tests for chronic viral hepatitis. Celiac disease screening test. Measurement of fasting blood sugar. A1C test. Lipid profile. Imaging procedures: Abdominal ultrasound, which is often the first test used when liver disease is suspected. Magnetic resonance imaging (MRI) or computerized tomography (CT) scanning. These tests are better at finding excess liver fat and cirrhosis. Transient elastography, a newer type of ultrasound that measures the stiffness of the liver. Liver stiffness is a sign of scarring. Magnetic resonance elastography, which combines MRI with sound waves to create a visual map showing the stiffness of body tissues. Liver biopsy: If other tests show signs of MASH, or if your test results are unclear, your healthcare professional may suggest a liver biopsy. Liver biopsy is a procedure to remove a small piece of tissue from your liver. It is usually done using a needle passed through the abdominal wall. The tissue sample is looked at in a lab for signs of inflammation and scarring. Liver biopsy is a way to diagnose MASH and find out the amount of liver damage, but in most people, noninvasive imaging tests are used instead.",
    "abstract": "MASLD常无症状，多因其他检查发现肝酶升高而诊断。诊断方法包括血液检测（肝酶、肝功能、血糖、血脂等）、影像学检查（腹部超声、MRI/CT、瞬时弹性成像、磁共振弹性成像）和肝活检。肝活检是诊断MASH和评估肝损伤的金标准，但通常首选无创检查。",
    "source": "Mayo Clinic, https://www.mayoclinic.org/diseases-conditions/nonalcoholic-fatty-liver-disease/diagnosis-treatment/drc-20354573"
  },
  {
    "disease_name": "脂肪肝",
    "category": "消化系统疾病",
    "information": "2025年6月发表在《肝病学杂志》上的一项研究发现：如果将每天吃东西的时间限制在8个小时内，仅需4个月，肝脏脂肪含量就能显著减少23.7％，并且还降低了体重、改善了身体代谢等。其实这就是目前网上比较火的“16＋8”饮食法，即把每天吃饭的时间，压缩在连续的8小时之内，剩下的16小时，除了喝水、茶（不加糖奶）等，不吃任何有热量的食物。研究结果发现，4个月后，“16＋8”饮食组肝脏脂肪含量显著减少23.7％，其效果与少吃节食组相当（该组减少24.7％）。然而，正常吃饭组的肝脏脂肪反而增加了0.7％。此外，实验还发现：限时饮食组（“16＋8”饮食）体重减轻了4.6％，并且腰围和内脏脂肪显著减少。适当合理地尝试“16＋8”饮食法，还有助于促进新陈代谢、改善多项身体指标，并为身体带来抗炎、抗衰老等多重益处。2025年1月，《自然医学》期刊上发表的一项研究发现：如果每天下午5点后不吃东西，坚持“16＋8”饮食方法（9：00~17：00进食），仅仅3个月后，不仅有助于减肥，还能更大程度地减少腹部皮下脂肪，并改善血糖水平，从而促进心血管健康。除了改善脂肪肝、血糖外，这种饮食方法还能带来抗炎、抗衰老的益处。",
    "abstract": "2025年《肝病学杂志》研究显示，采用“16+8”限时饮食法（8小时内进食，16小时禁食）4个月，可显著减少肝脏脂肪含量23.7%，效果与传统节食相当，并能减轻体重、减少腰围和内脏脂肪，改善代谢。该饮食法还有抗炎、抗衰老益处。",
    "source": "北京市政府门户网站, https://www.beijing.gov.cn/fuwu/bmfw/jhsyfwzdzx/2025qmjk/jkzhn/202508/t20250820_4177589.html"
  },
  {
    "disease_name": "脂肪肝",
    "category": "消化系统疾病",
    "information": "非酒精性脂肪性肝病（NAFLD）分为非酒精性脂肪肝（NAFL，单纯脂肪变）和非酒精性脂肪性肝炎（NASH）。NAFL仅肝细胞大泡性脂肪沉积，无气球样变或炎症；NASH则合并气球样变、混合炎细胞浸润及不同程度纤维化。胰岛素抵抗是核心机制，导致外周脂肪分解增加、肝脂肪酸合成增多及氧化减少，最终甘油三酯沉积。氧化应激与脂质过氧化触发炎症级联，激活星状细胞产生胶原，进展为纤维化。肝活检组织学分型：1型仅脂肪变；2型脂肪变+小叶炎症；3型脂肪变+气球样变；4型脂肪变+气球样变+马洛里小体或纤维化；3、4型即NASH。肥胖者NAFLD检出率高达90%，其中20–30%已进展为NASH。",
    "abstract": "NAFLD分单纯脂肪变（NAFL）与脂肪性肝炎（NASH），后者伴气球样变、炎症及纤维化。胰岛素抵抗驱动脂肪沉积，氧化应激促炎症与胶原生成。肥胖人群患病率90%，其中约1/4已进展为NASH。",
    "source": "StatPearls - NCBI Bookshelf, https://www.ncbi.nlm.nih.gov/books/NBK441992/"
  },
  {
    "disease_name": "脂肪肝",
    "category": "消化系统疾病",
    "information": "在西方人群，超声检出任何程度脂肪肝的患病率为21–45%；系统综述显示全球NAFLD患病率为20–30%，且随肥胖流行持续上升。年龄40–65岁男性最高发；西班牙人种患病率高于白人与非洲裔。肥胖者接受减重手术时，90%存在NAFLD，其中部分已伴肝硬化。NASH在一般人群中的患病率约3–5%，年发病率（超声法）为每千人2–10例。",
    "abstract": "超声调查西方成人脂肪肝患病21–45%，全球NAFLD约20–30%。40–65岁男性及西班牙人种更高；肥胖手术人群90%伴NAFLD，一般人群NASH患病率3–5%。",
    "source": "PMC - Epidemiology of fatty liver: An update, https://pmc.ncbi.nlm.nih.gov/articles/PMC4112887/"
  },
  {
    "disease_name": "脂肪肝",
    "category": "消化系统疾病",
    "information": "脂肪肝通常无症状，部分患者感右上腹隐痛或乏力。进展至MASH/肝硬化时可出现皮肤瘙痒、腹水、下肢水肿、蜘蛛痣、脾大、黄疸、黑便或呕血。晚期并发症包括门脉高压食管静脉曲张破裂出血、肝性脑病、肝肾综合征及肝癌。MASH患者10–20年内肝硬化风险达15–25%，一旦肝硬化形成，每年肝癌发生率为1–2%。",
    "abstract": "脂肪肝多无症状，进展后可出现腹痛、乏力、黄疸、腹水等。MASH 10–20年肝硬化风险15–25%，肝硬化后年肝癌率1–2%，并可并发门脉高压出血与肝性脑病。",
    "source": "NIDDK - Definition & Facts of NAFLD & NASH, https://www.niddk.nih.gov/health-information/liver-disease/nafld-nash/definition-facts"
  },
  {
    "disease_name": "脂肪肝",
    "category": "消化系统疾病",
    "information": "澳大利亚约1/3成人患脂肪肝，多数可通过生活方式逆转。诊断标准：肝脂肪>5%肝重；超声/CT/MRI提示弥漫性脂肪变；或肝活检证实。治疗核心：减少酒精、控制体重、均衡饮食（降低饱和脂肪与添加糖）、每周规律运动。若出现黄疸、呕血、黑便、腹胀或下肢水肿，应立即就医以排除肝硬化并发症。",
    "abstract": "澳大利亚成人脂肪肝患病率约33%，诊断基于影像或肝脂肪>5%。治疗以戒酒、减重、均衡饮食与运动为主；出现黄疸、出血、腹水等警示症状需及时就医排查肝硬化。",
    "source": "Healthdirect Australia, https://www.healthdirect.gov.au/fatty-liver"
  },
    {
    "disease_name": "脂肪肝",
    "category": "消化系统疾病",
    "information": "Fatty liver disease means you have extra fat in your liver. You might hear your doctor call it hepatic steatosis. Heavy drinking makes you more likely to get it. Over time, too much alcohol leads to a buildup of fat inside your liver cells. This makes it harder for your liver to work. But you can get fatty liver disease even if you don't drink a lot of alcohol. There are two main types: Nonalcoholic fatty liver disease (NAFLD) and Alcoholic fatty liver disease (AFLD). NAFLD is the most common chronic liver condition in the U.S. About 100 million people are estimated to have NAFLD. AFLD is less common, affecting about 5% of people in the U.S. In many cases, fatty liver disease doesn't cause any serious problems or prevent your liver from functioning normally. But for 7% to 30% of people with the condition, fatty liver disease gets worse over time. It progresses through three stages: Your liver becomes inflamed (swollen), which damages its tissue. This stage is called steatohepatitis. Scar tissue forms where your liver is damaged. This process is called fibrosis. Extensive scar tissue replaces healthy tissue. At this point, you have cirrhosis of the liver.",
    "abstract": "脂肪肝是肝脏内脂肪堆积过多的疾病，分为酒精性脂肪肝病和非酒精性脂肪肝病。美国约1亿人患有非酒精性脂肪肝，是最常见的慢性肝病。疾病可进展为脂肪性肝炎、肝纤维化和肝硬化，约7%-30%患者会经历疾病进展。早期通常无症状，不影响肝功能。",
    "source": "Cleveland Clinic, https://my.clevelandclinic.org/health/diseases/15831-fatty-liver-disease"
  },
  {
    "disease_name": "脂肪肝",
    "category": "消化系统疾病",
    "information": "Fatty liver disease is a common condition caused by the storage of extra fat in the liver. Most people have no symptoms, and it doesn't cause serious problems for them. In some cases, though, it can lead to liver damage. The good news is you can often prevent or even reverse fatty liver disease with lifestyle changes. The liver is your largest internal organ. It helps your body digest food, store energy, and remove poisons. Fatty liver disease is a condition in which fat builds up in your liver. There are two main types: Nonalcoholic fatty liver disease (NAFLD) and Alcoholic fatty liver disease, also called alcoholic steatohepatitis. NAFLD includes nonalcoholic fatty liver (NAFL) and nonalcoholic steatohepatitis (NASH). NAFLD is increasingly common around the world, especially in Western nations. In the United States, it is the most common form of chronic liver disease, affecting about one-quarter of the population.",
    "abstract": "脂肪肝是肝脏内脂肪异常堆积的常见疾病，多数患者无症状且无严重问题。分为非酒精性和酒精性两大类。非酒精性脂肪肝在美国影响约四分之一人口，是全球日益普遍的慢性肝病。通过生活方式改变通常可以预防或逆转疾病进展。",
    "source": "Johns Hopkins Medicine, https://www.hopkinsmedicine.org/health/conditions-and-diseases/nonalcoholic-fatty-liver-disease"
  },
  {
    "disease_name": "脂肪肝",
    "category": "消化系统疾病",
    "information": "Fatty liver disease is a build-up of fats in the liver that can damage the organ and lead to serious complications. Risk factors include obesity, a high-fat diet, high alcohol intake and diabetes mellitus. In most cases, people with fatty liver disease are encouraged to modify their diets, take regular exercise and lose weight. The liver is the largest solid organ in the body. It helps the body digest food, store energy and remove toxins. Fatty liver disease occurs when too much fat builds up in liver cells. Although it is normal to have a tiny amount of fat in these cells, the liver is considered fatty if more than 5 percent of its weight is fat. There are two main types of fatty liver disease: alcohol-related fatty liver disease and non-alcoholic fatty liver disease (NAFLD). NAFLD is one of the most common causes of liver disease in the United States. Most individuals with NAFLD have few or no symptoms. Patients may experience fatigue or vague abdominal discomfort. The liver may become slightly enlarged and some patients may develop jaundice.",
    "abstract": "脂肪肝是肝脏细胞脂肪过度堆积（超过肝脏重量5%）的疾病，可导致器官损伤和严重并发症。危险因素包括肥胖、高脂饮食、大量饮酒和糖尿病。大多数患者无症状或仅有疲劳、腹部不适，肝脏可能轻度肿大。治疗重点是饮食调整、规律运动和减重。",
    "source": "Medical News Today, https://www.medicalnewstoday.com/articles/312536"
  },
  {
    "disease_name": "脂肪肝",
    "category": "消化系统疾病",
    "information": "Fatty liver disease is a condition where excess fat is stored in the liver. This buildup of fat can lead to liver inflammation and damage. There are two main types: Alcoholic fatty liver disease, caused by heavy alcohol consumption, and Nonalcoholic fatty liver disease (NAFLD), which occurs in people who drink little to no alcohol. NAFLD is further divided into: Simple fatty liver (steatosis) - harmless buildup of fat in the liver cells. Nonalcoholic steatohepatitis (NASH) - fat buildup accompanied by liver inflammation, which can lead to scarring (fibrosis) and cirrhosis. NAFLD is often called a silent disease because it may not cause any symptoms, especially in the early stages. When symptoms do occur, they may include: Fatigue, Weakness, Weight loss, Loss of appetite, Nausea, Abdominal pain (especially in the upper right abdomen), Spider-like blood vessels, Yellowing of the skin and eyes (jaundice), Itching, Swelling in the legs and abdomen.",
    "abstract": "脂肪肝是肝脏脂肪异常堆积的疾病，分为酒精性和非酒精性。非酒精性脂肪肝又分为单纯性脂肪肝和脂肪性肝炎，后者可导致肝纤维化、肝硬化。早期通常无症状，进展后可能出现疲劳、腹痛、食欲不振、黄疸、腹水等症状。",
    "source": "Healthline, https://www.healthline.com/health/fatty-liver"
  },
  {
    "disease_name": "脂肪肝",
    "category": "消化系统疾病",
    "information": "Fatty liver disease is a common condition caused by having too much fat build up in your liver. A healthy liver contains a small amount of fat. It becomes a problem when fat reaches 5% to 10% of your liver's weight. There are two main forms of fatty liver disease: Alcohol-induced fatty liver disease and Nonalcoholic fatty liver disease (NAFLD). NAFLD is the most common liver disease in the United States. It's estimated that about 25% of adults in the U.S. have NAFLD. About 20% of people with NAFLD have NASH. NASH is the more severe form of NAFLD. NASH can cause cirrhosis and liver cancer. Most people with fatty liver disease have no symptoms. However, some people may experience tiredness or pain in the upper right side of their abdomen. The most common cause of fatty liver disease is alcohol use. Other causes include obesity, type 2 diabetes, high cholesterol, and metabolic syndrome.",
    "abstract": "脂肪肝是肝脏脂肪堆积超过肝脏重量5%-10%的常见疾病。美国约25%成人患有非酒精性脂肪肝，其中约20%进展为更严重的非酒精性脂肪性肝炎，可导致肝硬化和肝癌。多数患者无症状，部分可能出现疲劳或右上腹痛。主要病因包括饮酒、肥胖、2型糖尿病等。",
    "source": "WebMD, https://www.webmd.com/hepatitis/fatty-liver-disease"
  },
  {
    "disease_name": "脂肪肝",
    "category": "消化系统疾病",
    "information": "Fatty liver disease (steatosis) is a common condition caused by having too much fat build up in your liver. A healthy liver contains a small amount of fat. It becomes a problem when fat reaches 5% to 10% of your liver's weight. The liver is the body's largest internal organ. It helps your body digest food, store energy, and remove toxins. Fatty liver disease can occur when there's too much fat in the liver. There are two main types: Nonalcoholic fatty liver disease (NAFLD) and Alcoholic fatty liver disease. NAFLD is a condition in which fat builds up in the livers of people who drink little or no alcohol. NAFLD is the most common liver disease in the United States, affecting an estimated 80 to 100 million people. Most people with NAFLD have simple fatty liver (also called nonalcoholic fatty liver, or NAFL). Simple fatty liver means there's fat in the liver but little or no inflammation or liver cell damage. Simple fatty liver typically does not progress to cause liver damage. A small number of people with NAFLD have nonalcoholic steatohepatitis (NASH). NASH is a form of NAFLD in which you have inflammation of the liver and liver cell damage, in addition to fat in the liver. Inflammation and liver cell damage can cause fibrosis, or scarring, of the liver. NASH may lead to cirrhosis, in which the liver is scarred and permanently damaged. Cirrhosis can lead to liver cancer.",
    "abstract": "脂肪肝是肝脏脂肪堆积超过重量5%-10%的常见疾病，美国约8000万至1亿人患病。分为非酒精性和酒精性两类。大多数非酒精性脂肪肝患者为单纯性脂肪肝，不会进展为肝损伤；少数发展为非酒精性脂肪性肝炎，可导致肝纤维化、肝硬化和肝癌。",
    "source": "MedlinePlus, https://medlineplus.gov/fattyliverdisease.html"
  },
      {
        "disease_name": "脂肪肝",
        "category": "消化系统疾病",
        "information": "非酒精性脂肪肝病（NAFLD）是一种肝脏疾病，表现为肝脏内脂肪积聚，但与过量饮酒无关。NAFLD包括两种类型：非酒精性脂肪肝（NAFL）和非酒精性脂肪性肝炎（NASH）。NAFL是脂肪在肝脏内的积聚，而NASH则伴有肝脏炎症和损伤。NAFLD可能导致肝纤维化、肝硬化，甚至肝癌。",
        "abstract": "非酒精性脂肪肝病（NAFLD）是一种肝脏疾病，表现为肝脏内脂肪积聚，但与过量饮酒无关。NAFLD包括两种类型：非酒精性脂肪肝（NAFL）和非酒精性脂肪性肝炎（NASH）。NAFLD可能导致肝纤维化、肝硬化，甚至肝癌。",
        "source": "MedlinePlus - Nonalcoholic Fatty Liver Disease (https://medlineplus.gov/ency/article/007657.htm)"
    },
    {
        "disease_name": "脂肪肝",
        "category": "消化系统疾病",
        "information": "NAFLD的全球患病率约为30%，并且随着时间的推移有所增加。该疾病的患病率在男性中较高，约为40%，而在女性中约为26%。NAFLD的患病率在不同地区有所不同，非洲约为13.5%，中东地区约为31.8%。",
        "abstract": "NAFLD的全球患病率约为30%，并且随着时间的推移有所增加。该疾病的患病率在男性中较高，约为40%，而在女性中约为26%。NAFLD的患病率在不同地区有所不同，非洲约为13.5%，中东地区约为31.8%。",
        "source": "PubMed - The global epidemiology of nonalcoholic fatty liver disease (https://pubmed.ncbi.nlm.nih.gov/36626630/)"
    },
    {
        "disease_name": "脂肪肝",
        "category": "消化系统疾病",
        "information": "NAFLD的主要危险因素包括肥胖、2型糖尿病、高血压和高胆固醇血症。即使在体重正常的人群中，NAFLD的发生率也有所增加。年龄增长和男性也是NAFLD的已知危险因素。",
        "abstract": "NAFLD的主要危险因素包括肥胖、2型糖尿病、高血压和高胆固醇血症。即使在体重正常的人群中，NAFLD的发生率也有所增加。年龄增长和男性也是NAFLD的已知危险因素。",
        "source": "PubMed - Risk factors in nonalcoholic fatty liver disease (https://pubmed.ncbi.nlm.nih.gov/36517003/)"
    },
    {
        "disease_name": "脂肪肝",
        "category": "消化系统疾病",
        "information": "NAFLD的症状可能包括疲劳和白天嗜睡，这些症状可能是患者首次就医的原因，并可能显著影响生活质量。NAFLD患者可能还会出现非特异性的症状，如上腹部不适，但许多患者在早期阶段可能没有明显症状。",
        "abstract": "NAFLD的症状可能包括疲劳和白天嗜睡，这些症状可能是患者首次就医的原因，并可能显著影响生活质量。NAFLD患者可能还会出现非特异性的症状，如上腹部不适，但许多患者在早期阶段可能没有明显症状。",
        "source": "PubMed - Systemic symptoms in non-alcoholic fatty liver disease (https://pubmed.ncbi.nlm.nih.gov/20460914/)"
    }
]